Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 860.55 | 6943.33 | 10571.13 | 0.6562 | 0.7772 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 2500.00 | 860.55 | 1513.50 | 10571.13 | 0.1432 | 0.1643 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 860.55 | 1132.50 | 10571.13 | 0.1071 | 0.0777 |
| MCF 10A | Erlotinib | 10 | uM | 9 | 2500.00 | 860.55 | 1122.00 | 10571.13 | 0.1062 | 0.0756 |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 860.55 | 1044.17 | 10571.13 | 0.0988 | 0.0543 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2099.14 | 11030.00 | 11334.13 | 0.9733 | 0.9777 |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2099.14 | 11076.67 | 11334.13 | 0.9763 | 0.9794 |
| MCF 10A | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2099.14 | 11373.50 | 11334.13 | 1.0024 | 1.0012 |
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2099.14 | 11130.00 | 11334.13 | 0.9812 | 0.9838 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2099.14 | 8531.17 | 11334.13 | 0.7519 | 0.7777 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 5000.00 | 2099.14 | 3485.00 | 11334.13 | 0.3069 | 0.2228 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2099.14 | 2700.33 | 11334.13 | 0.2385 | 0.1070 |
| MCF 10A | Erlotinib | 10 | uM | 9 | 5000.00 | 2099.14 | 2629.00 | 11334.13 | 0.2324 | 0.0960 |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2099.14 | 2409.83 | 11334.13 | 0.2130 | 0.0575 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 92.36 | 138.50 | 128.38 | 1.0804 | 1.5722 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 156.25 | 92.36 | 130.83 | 128.38 | 1.0370 | 1.8646 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 171.33 | 128.38 | 1.3157 | 2.4590 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 156.25 | 92.36 | 152.00 | 128.38 | 1.1719 | 2.1719 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 161.00 | 128.38 | 1.2345 | 2.0719 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 156.25 | 92.36 | 109.17 | 128.38 | 0.8535 | 0.4344 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 105.33 | 128.38 | 0.8113 | 0.3575 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 156.25 | 92.36 | 76.00 | 128.38 | 0.6032 | -0.2067 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 300.50 | 128.38 | 2.3369 | 14.6833 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 200.50 | 368.17 | 334.54 | 1.1020 | 1.3427 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 312.50 | 200.50 | 412.00 | 334.54 | 1.2408 | 1.8080 |